What is evisit?
Founded in 2014 and based in Mesa, Arizona, eVisit operates at the intersection of healthcare and technology, aiming to improve outcomes, reduce costs, and boost revenue across enterprise service lines and departments. The company's platform is designed to facilitate seamless integration within healthcare systems, addressing critical needs in patient engagement and operational efficiency. eVisit's focus on enterprise solutions positions it as a key player in the digital health transformation landscape.
How much funding has evisit raised?
evisit has raised a total of $66.7M across 6 funding rounds:
Angel/Seed
$1M
Private Equity
$4.4M
Angel/Seed
$2M
Debt
$350K
Series A
$14M
Series B
$45M
Angel/Seed (2015): $1M, investors not publicly disclosed
Private Equity (2016): $4.4M, investors not publicly disclosed
Angel/Seed (2017): $2M supported by Arizona Founders Fund and Kickstart Seed Fund
Debt (2020): $350K featuring PPP
Series A (2020): $14M backed by TVC Capital, Jeremy Andrus, University Growth Fund, and Kickstart Seed Fund
Series B (2021): $45M with participation from Goldman Sachs
Key Investors in evisit
Goldman Sachs
Goldman Sachs is a leading global investment banking firm, known for its extensive involvement in capital markets and providing financial services to corporations and institutions worldwide. Their participation suggests a significant endorsement of eVisit's enterprise potential.
TVC Capital
TVC Capital is a growth equity firm that specializes in investments and acquisitions of software companies. Their focus on B2B software aligns with eVisit's enterprise-level solutions, indicating a strategic interest in scaling the company's technology.
Kickstart Seed Fund
Kickstart Seed Fund is a venture capital firm focused on pre-seed and seed funding for startups, particularly in the Mountain West region. Their involvement in multiple rounds, including Series A, highlights their early and ongoing support for eVisit's development and growth.
What's next for evisit?
The recent major strategic investment signals a pivotal phase for eVisit, likely enabling accelerated product development, market expansion, and enhanced customer support. This infusion of capital is expected to fuel the company's efforts to further solidify its presence in the competitive healthcare technology sector. Strategic partnerships and technological advancements will be crucial as eVisit navigates the evolving demands of healthcare providers and patients, aiming to capitalize on its established foundation and investor backing for sustained growth and innovation.
See full evisit company page
